{
  "doc_id": "Leprechaunism",
  "doc_filename": "Leprechaunism.pdf",
  "top_entities": [
    {
      "name": "leprechaunism",
      "mention_count": 1,
      "entity_type": "disease"
    }
  ],
  "file_size_bytes": 1566,
  "file_size_human": "1.5 KB",
  "file_extension": ".pdf",
  "pdf_title": "(anonymous)",
  "pdf_author": "(anonymous)",
  "pdf_page_count": 1,
  "pdf_creation_date": "2026-01-07T22:25:17",
  "doi": null,
  "doi_url": null,
  "document_type_code": "CRM",
  "document_type_name": "Clinical Research Materials",
  "document_type_group": "Clinical Research Materials",
  "classification_confidence": 0.15,
  "title": "Leprechaunism: Clinical Overview and Epidemiological Data",
  "short_description": "Clinical document presenting epidemiological data on leprechaunism, including gender distribution and historical background of the condition first identified by Dr. W.L. Donohue in 1948.",
  "long_description": "This clinical research document provides epidemiological information about leprechaunism, a rare genetic disorder. The document reports that leprechaunism occurs twice as frequently in females compared to males, with more than 50 cases documented in medical literature. It includes historical context, noting that the condition was first identified in 1948 by Dr. W.L. Donohue. The document appears to be part of a larger clinical reference or research compilation focusing on the prevalence and demographic characteristics of this rare endocrine disorder.",
  "document_date": "2026-01-07T22:25:17",
  "document_date_source": "pdf_metadata",
  "extraction_timestamp": "2026-02-05T01:31:06.147693"
}